When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

We recently published a list of These 10 Firms Took A Hit on Friday. In this article, we are going to take a look at where ...

Apple stock rises after falling Thursday by the most since August, Alphabet stock is up after the Supreme Court upholds a ban ...

Novo is currently in a golden age of growth. Over the last five years, its trailing-12-month revenue grew by 109%, reaching ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

Official data shows that since 2019, this medication has been linked to 23 deaths and 1,179 serious adverse reactions in the ...

Weight loss jabs are now are now available on the NHS for those with a prescription. But a black market for the in-demand ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

One of the hottest growth areas in the healthcare landscape these days is the obesity drug market because of a class of drugs ...

It hasn't been a great period for investors in Novo Nordisk (NYSE ... that Wegovy is actually more effective than the other product. As of Dec. 4, there's no reason for it to be that confident ...

Novo Nordisk Call and Put Volume: 30-Day Overview With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world.